Advertisement

Research Article Free access | 10.1172/JCI118231

Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

S Nozaki, H Kashiwagi, S Yamashita, T Nakagawa, B Kostner, Y Tomiyama, A Nakata, M Ishigami, J Miyagawa, and K Kameda-Takemura

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Nozaki, S. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kashiwagi, H. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Yamashita, S. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Nakagawa, T. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kostner, B. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Tomiyama, Y. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Nakata, A. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Ishigami, M. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Miyagawa, J. in: JCI | PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kameda-Takemura, K. in: JCI | PubMed | Google Scholar

Published October 1, 1995 - More info

Published in Volume 96, Issue 4 on October 1, 1995
J Clin Invest. 1995;96(4):1859–1865. https://doi.org/10.1172/JCI118231.
© 1995 The American Society for Clinical Investigation
Published October 1, 1995 - Version history
View PDF
Abstract

To clarify the physiological roles of CD36 as an oxidized low density lipoprotein (OxLDL) receptor, we analyzed the monocyte-derived macrophages from normal and two CD36-deficient subjects, since we identified the molecular abnormalities (Kashiwagi, H., Y. Tomiyama, Y. Kosugi, M. Shiraga, R. H. Lipsky, Y. Kanayama, Y. Kurata, and Y. Matsuzawa 1994. Blood. 83:3545-3552; and Kashiwagi, H., Y. Tomiyama, S. Honda, S. Kosugi, M. Shiraga, N. Nagao, S. Sekiguchi, Y. Kanayama, Y. Kurata, and Y. Matsuzawa. 1995. J. Clin. Invest. 95:1040-1046). Scatchard analysis of 125I-OxLDL binding showed a linear plot and the maximum binding was lower by approximately 40% in the macrophages from subjects with CD36 deficiency than those from normal controls. Competition studies showed that the uptake of 125I-OxLDL was suppressed by OKM5, an antibody against CD36, by 53% in normal control macrophages, but not in the CD36-deficient macrophages. After incubation with OxLDL for 24 h, cholesteryl ester mass accumulation was reduced by approximately 40% in the macrophages from CD36-deficient subjects than those from normal controls. These results suggest that CD36 is one of the physiological receptors for OxLDL. Since specific binding of OxLDL was only reduced by approximately 40% in spite of the complete deficiency of CD36, several other receptors also may have some role in OxLDL uptake. Further studies will be needed to assess the quantitative role of CD36 in foam cell formation in vivo.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (October 1, 1995): No description
Advertisement
Advertisement